Epsilon M&A Deal Report - Horus Pharma

Transaction Multiples for the Valuation of Private Companies

Eurazeo > Horus Pharma

Announced Date : 14 March 2022

Type : LBO (Leverage Buy Out)

Deal Value : Yes

Acquirer : Eurazeo

Target: Horus Pharma

Target Country: France

Sector of activity : Health, Pharmaceuticals & Biotechnology, Food & Beverage Industry

Business Description :

> Founded in 2003, Horus Pharma is an ophthalmology pharmaceuticals producer in France. ...

No EMAT : 109015

Transaction multiples available

	EV/Sales	EV/Gross Profit	EV/EBITDA	EV/EBIT	Eq/PBT	P/E	Price to Book
Historic
Current

: Multiple available

n.s : Multiple calculated, but not significant

Rating ***

Source: Epsilon Research / EMAT

Comparable Transactions

Number of EMAT Reports : (Food & Beverage Industry) = 750

Example of comparable transactions on EMAT (same sub-sector):

Date	Acquirer	Target	Country	Multiples	See details
28/02/2022	Funding round led SWEN Capital Partners, BNP Paribas Développement	Entomojo (Tomojo)	France	**
02/03/2020	Funding round led by business angels	Laboratoire pour la Santé Animale (LAPSA)	France	*

Source: Epsilon Research / EMAT

View Report

This report is accessible on EMAT, the reference database for private company acquisition multiples

Example of EMAT Report : click here

View Complete Report

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

Sectors covered by our analysts

Studies & indices published by Epsilon Research Register to receive (free) publications updates

EMAT Report

Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

Subscribe to EMAT database